Table of Contents
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Arteriotomy Closure Devices Overview 7
3 Products under Development 8
3.1 Arteriotomy Closure Devices – Pipeline Products by Stage of Development 8
3.2 Arteriotomy Closure Devices – Pipeline Products by Segment 9
3.3 Arteriotomy Closure Devices – Pipeline Products by Territory 10
3.4 Arteriotomy Closure Devices – Pipeline Products by Regulatory Path 11
3.5 Arteriotomy Closure Devices – Pipeline Products by Estimated Approval Date 12
3.6 Arteriotomy Closure Devices – Ongoing Clinical Trials 13
4 Arteriotomy Closure Devices – Pipeline Products under Development by Companies 14
4.1 Arteriotomy Closure Devices Companies – Pipeline Products by Stage of Development 14
4.2 Arteriotomy Closure Devices – Pipeline Products by Stage of Development 15
5 Arteriotomy Closure Devices Companies and Product Overview 16
5.1 Aporo Biomedical, Inc. (Inactive) Company Overview 16
5.1.1 Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 Boston Scientific Corp Company Overview 17
5.2.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 17
5.3 CardioDex Ltd (Inactive) Company Overview 22
5.3.1 CardioDex Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 22
5.4 CloSys Corp Company Overview 23
5.4.1 CloSys Corp Pipeline Products & Ongoing Clinical Trials Overview 23
5.5 Conformal Medical Inc Company Overview 24
5.5.1 Conformal Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 24
5.6 Cor Habere Corp Company Overview 27
5.6.1 Cor Habere Corp Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 CPC of America Inc Company Overview 28
5.7.1 CPC of America Inc Pipeline Products & Ongoing Clinical Trials Overview 28
5.8 Dextera Surgical Inc Company Overview 29
5.8.1 Dextera Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 29
5.9 Essential Medical Inc Company Overview 30
5.9.1 Essential Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 30
5.10 Harvard University Company Overview 33
5.10.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 33
5.11 Mayo Clinic Company Overview 34
5.11.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 34
5.12 ProMed Inc Company Overview 35
5.12.1 ProMed Inc Pipeline Products & Ongoing Clinical Trials Overview 35
5.13 Rex Medical LP Company Overview 36
5.13.1 Rex Medical LP Pipeline Products & Ongoing Clinical Trials Overview 36
5.14 SentreHEART Inc Company Overview 38
5.14.1 SentreHEART Inc Pipeline Products & Ongoing Clinical Trials Overview 38
5.15 Sheba Medical Center Company Overview 39
5.15.1 Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 39
5.16 Terumo Interventional Systems Company Overview 40
5.16.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview 40
5.17 University of Rochester Company Overview 41
5.17.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 41
5.18 Vascular Closure Systems Inc Company Overview 42
5.18.1 Vascular Closure Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 42
5.19 Vivasure Medical Ltd. Company Overview 46
5.19.1 Vivasure Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 46
6 Arteriotomy Closure Devices- Recent Developments 49
6.1 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships 49
6.2 Nov 07, 2019: Cardinal Health reports first quarter results for fiscal year 2020 49
6.3 Oct 30, 2019: Cardiva Medical announces publication of data From the AMBULATE pivotal study in the Journal of the American College of Cardiology: Clinical Electrophysiology 51
6.4 Sep 23, 2019: Conformal Medical announces presentation of US feasibility study data at TCT 2019 in San Francisco 52
6.5 Sep 18, 2019: Boston Scientific announces scheduled presentations at Transcatheter Cardiovascular Therapeutics 2019 52
7 Appendix 75
7.1 Methodology 75
7.2 About GlobalData 78
7.3 Contact Us 78
7.4 Disclaimer 78
Table 1: Arteriotomy Closure Devices - Pipeline Products by Stage of Development
Table 2: Arteriotomy Closure Devices - Pipeline Products by Segment
Table 3: Arteriotomy Closure Devices - Pipeline Products by Territory
Table 4: Arteriotomy Closure Devices - Pipeline Products by Regulatory Path
Table 5: Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date
Table 6: Arteriotomy Closure Devices - Ongoing Clinical Trials
Table 7: Arteriotomy Closure Devices Companies - Pipeline Products by Stage of Development
Table 8: Arteriotomy Closure Devices - Pipeline Products by Stage of Development
Table 9: Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Femoral Artery Closure Device - Product Status
Table 11: Femoral Artery Closure Device - Product Description
Table 12: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 13: WATCHMAN FLX - Product Status
Table 14: WATCHMAN FLX - Product Description
Table 15: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 16: WATCHMAN FLX - Compare Safety and Effectiveness of WATCHMAN FLX Left Atrial Appendage Closure (LAAC) and warfarin for Stroke Risk Reduction in Patients with Non-valvular Atrial Fibrillation (AF)
Table 17: WATCHMAN FLX - I Can See Left Atrial Appendage (ICELAA) Clinical Study
Table 18: WATCHMAN FLX - Protection Against Embolism for Non-valvular AF Subjects: Investigational Device Evaluation of the WATCHMAN FLX LAA Closure Technology
Table 19: WATCHMAN FLX - Watchman FLX Left Atrial Appendage Closure Device Post Approval Study
Table 20: CardioDex Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 21: EpiClose Plus - Product Status
Table 22: EpiClose Plus - Product Description
Table 23: CloSys Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 24: CloSys HD - Product Status
Table 25: CloSys HD - Product Description
Table 26: Conformal Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Left Atrial Appendage Seal - LAA Occlusion - Product Status
Table 28: Left Atrial Appendage Seal - LAA Occlusion - Product Description
Table 29: Conformal Medical Inc - Ongoing Clinical Trials Overview
Table 30: Left Atrial Appendage Seal - LAA Occlusion - The CONFORMAL Early Feasibility Study an Evaluation of the Safety and Performance of the Conformal Left Atrial Appendage Seal for Left Atrial Appendage Occlusion
Table 31: Left Atrial Appendage Seal - LAA Occlusion - The Conformal Prague Study: An Evaluation of the Safety and Performance of the Conformal Left Atrial Appendage Seal for Left Atrial Appendage Occlusion
Table 32: Cor Habere Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 33: StrokeShield System - Product Status
Table 34: StrokeShield System - Product Description
Table 35: CPC of America Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 36: MedClose - Product Status
Table 37: MedClose - Product Description
Table 38: Dextera Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: X-Port Vascular Access Closure Device - Product Status
Table 40: X-Port Vascular Access Closure Device - Product Description
Table 41: Essential Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 42: MANTA - Product Status
Table 43: MANTA - Product Description
Table 44: Essential Medical Inc - Ongoing Clinical Trials Overview
Table 45: MANTA - MANTA Versus Suture-based Closure after Transcatheter Aortic Valve Implantation Trial
Table 46: MANTA - Post-market Clinical Registry to Evaluate the Safety and Performance of MANTA Vascular Closure Device (VCD) Under Real World Conditions in the European Union (EU)
Table 47: Harvard University Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Access-Closure Device - Product Status
Table 49: Access-Closure Device - Product Description
Table 50: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
Table 51: Left Atrial Appendage Closure Device - Product Status
Table 52: Left Atrial Appendage Closure Device - Product Description
Table 53: ProMed Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Large Hole Closure Device - Product Status
Table 55: Large Hole Closure Device - Product Description
Table 56: Rex Medical LP Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Auto-Close Vascular Sealing System - Product Status
Table 58: Auto-Close Vascular Sealing System - Product Description
Table 59: Large Bore Closer Vascular Sealing System - Product Status
Table 60: Large Bore Closer Vascular Sealing System - Product Description
Table 61: SentreHEART Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Eclipse Surgical Left Atrial Appendage Closure Device - Product Status
Table 63: Eclipse Surgical Left Atrial Appendage Closure Device - Product Description
Table 64: Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Table 65: Left Atrial Appendage Intraatrial Transcatheter Sutureless Closure - Product Status
Table 66: Left Atrial Appendage Intraatrial Transcatheter Sutureless Closure - Product Description
Table 67: Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
Table 68: Vascular Closure Device - Product Status
List of Figures
Figure 1: Arteriotomy Closure Devices - Pipeline Products by Stage of Development
Figure 2: Arteriotomy Closure Devices - Pipeline Products by Segment
Figure 3: Arteriotomy Closure Devices - Pipeline Products by Territory
Figure 4: Arteriotomy Closure Devices - Pipeline Products by Regulatory Path
Figure 5: Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date
Figure 6: Arteriotomy Closure Devices - Ongoing Clinical Trials
【免責事項】
https://www.marketreport.jp/reports-disclaimer